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Background:Recent findings strongly promoted the hypothesis that common pelvic gyne-
cological diseases including endometriosis and ovarian neoplasia may develop de novo
from ectopic endometrial-like glands and/or embryonic epithelial remnants. To verify the
frequency, the anatomical localization and the phenotype of misplaced endometrial tissue
along the fetal female reproductive tract, histological and immunohistochemical analyses of
uteri, fallopian tubes, and uterosacral ligaments were performed. Methods: Reproductive
organs were collected from seven female fetuses at autopsy, five of them from gestational
ages between 18 and 26 weeks and two fetuses with gestational ages of 33 and 36 weeks
deceased of placental anomalies. Serial sections from areas containing ectopic glands and
embryonic duct residues were analyzed by histological and immunohistochemical proce-
dures. Results: Numerous ectopic endometrial glands and stroma were detected in the
myometrium in two fetuses with low levels of expression of estrogen receptor-alpha (ER-α)
and progesterone receptors (PR).The embryonic ducts were localized in the uterine broad
and ovarian ligaments and under the fallopian tube serosa in six fetuses. Low levels of
steroid receptors expression were found in the embryonic residues, whereas the carcino-
embryonic antigen (CEA) and the tumor marker Ca 125 were not detected.The embryonic
residues stromal component strongly expressed the CD 10 and vimentin proteins. Con-
clusion: The anatomical and the immunohistochemical features of the ectopic organoid
structures identified in fetal female reproductive tract suggest that endometriotic as well
as neoplastic disease in adult women may develop on the basis of misplaced endometrial
glands and/or embryonic cell remnants.
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INTRODUCTION
Endometriosis is a heterogeneous gynecological disease clinically
characterized by the presence of different anatomo-clinical sub-
types (Giudice, 2010). The most frequently proposed pathogenetic
mechanism is tubal regurgitation during menstrual cycle, which
however cannot explain all clinical forms of this disease (Samp-
son, 1927; Bulun, 2009). Indeed, occurrence of endometriosis was
described in patients with Rokitansky–Kuster–Hauser syndrome
who does not have functioning endometrial tissue (Acien, 1986;
Cho et al., 2009) as well as in male patients with endometriosis of
the prostate, bladder, and the abdominal wall (Schrodt et al., 1980;
Beckman et al., 1985; Martin and Hauck, 1985). In this regard,
the theory of transformation of the vestigial tissue of Müllerian or
Wolfian origin and the coelomic metaplasia theory can explain the
origin of distinct entities of endometriotic lesions as well as devel-
opment of particular types of ovarian neoplasms (Ridley, 1968;
Suginami, 1991; Varma et al., 2004; Mandai et al., 2009; Wei et al.,
2011). In the same context, a recent study has proposed the fetal
origin of endometriosis, that could develop on the basis of altered
migration of primitive endometrial tissue during embryogenesis
(Signorile and Baldi, 2010). These authors assessed that the inci-
dence of the dislocated embryonic structures in fetuses is similar
to that of endometriosis occurring in the adult female population
(Signorile and Baldi, 2010). In the same direction, relationship
between endometriosis and malignancies arising in gonadal and
extragonadal endometrial implants become supported by several
clinical pathologic and molecular investigations (Brinton et al.,
1997; Vercellini et al., 2000; Varma et al., 2004; Prowse et al., 2006;
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Wei et al., 2011). These studies suggested that histogenetically,
endometriosis represents an important site of origin of ovarian
and other pelvic malignancies (Vercellini et al., 2000; Mandai et al.,
2009; Wei et al., 2011). It was described that such neoplasms are
constituted of clear epithelial cells and tend to be detected in ear-
lier stages, their prognosis being more favorable (McMeekin et al.,
1995; Wei et al., 2011). In addition, embryonic duct remnants were
often microscopically observed adjacent to ovarian tumors as well
as close to pelvic endometriotic lesions suggesting a pathogenetic
relationship (Rudgers and Scully, 1988; Mai et al., 1998; Dubeau,
2008; Nissenblatt, 2011).
In the present study, we evaluated the incidence and the
anatomical location of displaced endometrial tissue in the repro-
ductive tract in seven female fetuses. Serial sectioning of the repro-
ductive organs was realized followed by immunohistochemical
analysis of tissue areas containing ectopic glands and embryonic
cell rests. It was observed that the anatomical and the phenotypic
features of the mislocated tissue components recall some patho-
logical characteristics of both benign and malignant gynecological
conditions.
MATERIAL AND METHODS
TISSUE PREPARATION
Reproductive organs from a series of seven human female fetuses
at different gestational ages ranging from 18 to 36 weeks were
obtained at autopsy. All together, the causes of fetal death were
placental pathology in two samples, cardiac malformations in
two cases and voluntary abortions in three. The reproductive
organs were carefully dissected, fixed in buffered formaldehyde,
and included in paraffin.
Between 200 and 400 serial sections with thickness of 5–
7 mm from each paraffin block containing uteri, fallopian tubes,
ovaries, and uterosacral ligaments were prepared and stained by
hematoxylin and eosin (H&E). To ascertain tissue sections con-
taining ectopic endometrial glands and/or embryonic duct rem-
nants, every sixth slide was separately stained and microscopically
analyzed.
ANTIBODIES
The following antibodies were employed; rabbit anti estrogen
receptor-alpha (ER-α), (cat N˚ sc-54, Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA); monoclonal mouse anti human prog-
esterone receptor, clone PR 636 (Dako Laboratories Glostrup,
Denmark); monoclonal anti human CA125, clone M11 CA125
(Dako); monoclonal anti human CD10 clone 56C6 (Dako); mon-
oclonal anti human carcino-embryonic antigen (CEA) clone II-7
(Dako); rabbit anti human alpha-1-foetoprotein (Dako); mono-
clonal anti human epithelial membrane antigen (EMA) clone E29
(Dako); mouse anti human Cytokeratin 7 (clone RCK 105, cat N˚
sc-23876, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
and monoclonal mouse anti-vimentin clone VIM 3B (Dako).
IMMUNOHISTOCHEMISTRY
Five micrometres thick sections were deparaffinized in xylene,
rehydrated through graded alcohol series, and washed in PBS.
For antigen retrieval, the slides were immerged in citrate buffer
(pH= 6.0) during 25 min at 96˚C essentially as described (Hsu
et al., 1981). After brief wash in PBS, the appropriate dilu-
tion of the primary antibodies was applied on slides during
1 h. Immunoreactivity was revealed using the avidin-biotin com-
plex method (LSAB2 System HRP, Dako, Denmark) with 3,3′-
diaminobenzidine tetra hydrochloride (DAB) as a chromogen.
After checking the staining intensity, the sections were washed
in water and counterstained with Harris hematoxylin (Sigma-
Aldrich Chimie Sarl, Saint-Quentin Fallavier, France). The slides
were then dehydrated in ascending grades of ethanol and after
clearing the sections with xylene mount and they were covered
with DPX mountant (Merck Chimie SAS, Fontenay sous Bois,
France). Negative controls consisted of replacement of the primary
antibodies with non-immune mouse or rabbit serum or buffer
alone. The extent and the intensity of the staining were determined
by the objective observer procedure. Epithelial staining intensity
was graded on a 0–3 scale, where 0, no staining was assessed with
anti-rabbit secondary antibody alone; 1, weak; 2, moderate; and
3, intense staining. The percentage of immunoreactive cells was
obtained by counting the number of stained cells from a total of
200 cells at magnification of×20, composing the ectopic endome-
trial glands and stroma or embryonic duct structures and stroma
of each case and from each location.
RESULTS
Tissue sections of the reproductive organs from all fetuses stained
by hematoxylin an eosin showed normal anatomical morphology
and histological structure with asymmetrical uterine endometrial
branching invaginations, while inflammatory or fibrotic areas or
hemorrhage were not detected. In the fetuses of the lower gesta-
tional age, the uterine central cavities appeared lined by columnar
epithelial cells and were devoid of differentiated glandular struc-
tures. The uterine cavity of the 33 and 36 weeks old fetuses was
lined by epithelial cells forming rare immature glandular struc-
tures of different sizes. Remarkably, ectopic foci of glandular
structures surrounded by a densely distributed stromal cells were
found in serial sections of the uterine myometrium in two fetuses,
with gestational ages of 25 weeks and of 36 weeks (Figure 1). The
histological structure of the ectopic glands predominantly showed
a single layer of columnar cells similar to the endometrial epithelial
lining with basal nuclei and mucin containing cytoplasm. Some of
the misplaced glands of larger size showed focal cytological atypia
but mitotic figures were not observed. Histological appearance of
the ectopic glands distributed in the uterine wall of the 36-week-
old fetus is shown in Figure 2A. Of note, distinct large foci of
epithelial cellular elements forming tubular gland like structures
were present in the ovarian hilus in one fetus with gestational age
of 23 weeks (not shown).
The second form of ectopic structures observed were the
embryonic tubular duct formations located bilaterally in the broad
uterine and ovarian ligaments in five tissue samples and under the
fallopian tube serosa in one fetus, some of them being surrounded
by a dense endometrial-like stroma (Figure 1; Figures 2B–D). In
general, the embryonic structures present in the uterine and ovar-
ian ligaments histologically appeared as discontinuous segments of
tortuous ducts surrounded by a rich vascular network. Each duct
remnant exhibited a lumen lined by cuboidal cells, surrounded by
a layer of mesenchymal stroma like component. Interestingly, in
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FIGURE 1 | Schematic representation of the anatomical localization of
ectopic endometrial glands and embryonic duct remnants along the
reproductive tract of six female fetuses. Areas of the distribution of
ectopic glands in the myometrium (1) in two fetuses: (ellipses). Distribution
of embryonic ducts in the uterine broad ligaments (2), ovarian ligaments (3),
and under the fallopian tube serosa (4) in a total of six fetuses: (circles).
Abbreviations: ut, uterus; bl, bladder; va, vagina; ov, ovary; ft, fallopian tube;
re, rectum.
the 36 weeks old fetus, both embryonic ducts located in the broad
ligament and ectopic glands embedded in the myometrium were
simultaneously observed.
By immunohistochemistry, various levels of several marker
antigens were detected in both the ectopic uterine glands and
embryonic ducts. As a rule, a higher level of the EMA, PR, and
ER-α molecules were detected in cells lining the uterine cavity
with a mean of 64, 53, and 21% of labeled elements respectively. A
lower percentage of immunoreactivity for EMA (23%), PR (14%),
and ER-α (6%) was revealed in the ectopic glandular structures
localized in the uterine wall. A strong expression of CD10 (41.3%)
but lower level of vimentin specific immunolabeling (20%) was
observed in the stromal component surrounding the displaced
glands. Representative illustrations of PR expression in ortho-
topic endometrial cells as well as the expression of PR, ER-α,
and CD10 in the uterine ectopic glands and stroma are shown
in Figures 3A–D.
Concerning the embryonic remnants, consistent EMA
immunostaining ranging between 32 and 53% was detected in
the duct lining cells, while lower level of expression in duct
cells of both ER-α (10–23%) and PR (13–44%) molecules was
found in all samples. The stromal-like component surrounding
the duct residues contained between 1 and 3% of immunoreac-
tive cells for ER-α and between 4 and 13% of immunoreactive
cells for PR. Approximately 2–11% of the ductal cells and 1–3% of
the stormal cells expressed cytokeratin 7, while CEA and CA125
FIGURE 2 | Hematoxylin and Eosin stained sections with areas of
ectopic endometrial glands and embryonic ducts. Histological
appearance of ectopic glands and stroma observed (insert at higher
magnification) in fetal uterine wall (A). Presence of embryonic ducts
located in the broad ligament (B), under the fallopian tube serosa (C),
and ducts located in the ovarian ligament (D). Note presence of a
stromal component surrounding the duct residues in (A–D). Scale bars,
100µm.
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FIGURE 3 | Immunohistochemical analysis of ectopic endometrial
glands and embryonic ducts in fetal reproductive tract. Immunolabeling
with anti PR antibody of uterine cavity wall lining cells [(A), arrows].
Immunostaining of the fetal ectopic glands located in the uterine
myometrium with anti PR (B), anti ER-α (C), and anti CD10 antibodies (D).
Expression of the PR in embryonic duct located in the ovarian ligament;
insert at higher magnification (E), expression of ER-α in a duct located under
the fallopian tube serosa (F), and expression of alpha-1-fetoprotein (G) and
CD10 molecules (H). D=duct; St= stromal layer. Scale bars; 500µm in (A)
and 100µm in (B–H).
molecules were not detected. Using anti alpha-1-fetoprotein anti-
body, close to 42% of the epithelial and duct surrounding mes-
enchymal cells were intensely immunoreactive on sections from
two fetuses. Representative illustrations of the embryonic duct
residues labeled with anti ER-α, anti PR, anti alpha-1-fetoprotein
and anti CD10 antibodies are shown in Figures 3E–H. The mean
Frontiers in Physiology | Craniofacial Biology December 2012 | Volume 3 | Article 444 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bouquet de Jolinière et al. Ectopic glands in female fetuses
Table 1 | Summary of the percentages of immunoreactive cells in embryonic ducts and the surrounding stroma present in various locations of
the fetal reproductive tract.
Gestational age (weeks) EMA* Cytokeratin 7* ER* PR* Vimentin* CD10*
D St D St D St D St D St D St
18 32 − 2 − 10 − 19 11 35 4 2 55
19 52 − − − 12 − 21 6 26 9 − 38
20 38 − − 3 18 3 13 8 34 13 − 42
21 43 − − − 13 − 19 4 22 20 − 39
22 46 − − − 23 − 31 13 25 6 − 44
32 0 0 0 − 0 0 0 0 0 0 0 0
36 53 1 11 1 16 1 44 9 53 32 4 64
Mean value** 264 1 13 4 92 4 147 51 195 84 6 282
D, embryonic duct; St, Stromal layer; *, percentage of cells expressing the indicated marker; mean value** [represents a ratio of the number of counted cells (200)
divided by the number of immunolabeled cells].
values of the percentage of imunoreactive embryonic duct lining
cells and stroma against EMA, Cytokeratin 7, ER-α, PR, vimentin
and CD10 antigens are reported in Table 1.
DISCUSSION
In this study we show presence of misplaced endometrial glands
and embryonic duct-like remnants in the reproductive organs
in six of seven examined female fetuses. The phenotypic fea-
tures of the ectopic glands in the myometrium of two fetuses
indicate particularly weak expression of PR and ER-α steroid
hormone receptors in comparison to their high level of expres-
sion in cells lining the endometrial cavity. In these two cases,
moderate level of PR expression was also revealed in the cell
nuclei of the stromal component, while ER-α receptors were not
found. Overall, the presented findings are in accordance with
other studies describing the levels of ER-α and PR in misplaced
glands in patients with both endometriosis and adenomyosis (Van
der Walt et al., 1986; Ferenczy, 1998; Bulun et al., 2010). In
fact, inconsistent results concerning the pattern of steroid hor-
mones receptor expression in fetal female genital tissues were
reported by several studies (Glatstein and Yeh, 1995; Branden-
berger et al., 1997). For example, in adult patients, decreased
expression of both ER-α and PR were reported in seven cases of
ovarian endometriomas in comparison to their consistent levels
in the autologous endometrial cells (Tamaya et al., 1979). This is
in agreement with other observations indicating that adenomy-
otic nodules located in the vaginal fornix and the rectovaginal
septum do not express PR and ER-α suggesting that they may
originate from undifferentiated Müllerian residues (Nisolle and
Donnez, 1997; Donnez et al., 2003). Another study reported equal
levels of expression of ER and PR receptors in both autolo-
gous endometrium and the adenomyotic lesions in adult patients
(Ferenczy, 1998).
Concerning the foci of embryonic duct remnants observed,
moderate expression of PR and low levels of ER-α were uniformly
revealed in the epithelial cells in all cases. Histologically, some
ducts appeared dysplastic and surrounded by a dense cellular
stromal layer consistently expressing vimentin and CD10 mole-
cules. Of interest, these tubular structures in most of the samples
did not clearly express cytokeratin 7, and Ca 125 protein mole-
cules. This might be related to particular phenotypic features of
coelomic metaplastic cell rests at given gestational age (Batt and
Smith,1989; Fujii, 1991). Comparatively, consistent level of expres-
sion of both estrogen receptor and CA 125 antigens was described
in displaced organoid structures in fetal rectovaginal septum, the
Douglas pouch, the rectal tube, and at the posterior wall of fetal
uteri (Signorile et al., 2009).
In spite of the limited number of studied cases, the findings of
ectopic glands and/or embryonic ducts in the reproductive tract of
female fetuses is a remarkable phenomenon that could be referred
to the theory of involvement of Müllerian or Wolfian cell rests
in the pathogenesis of both endometriosis and particular pelvic
malignancies (Fujii, 1991; Redwine, 1998, 2003; Leiserowitz et al.,
2003; Batt et al., 2007; Signorile et al., 2009; Wei et al., 2011).
At present it is considered that a multitude of ovarian, adnexal,
and pelvic masses originate from the secondary Müllerian system.
On the other hand, it is well known that the coelomic epithelial
cells and the accompanying mesenchymal component referred as
secondary Müllerian system, have the potential to differentiate
toward a Müllerian-directed epithelium and stroma (Fujii, 1991;
Mai et al., 1997). Thus, it has been hypothesized that aberrant
migration of Müllerian ducts could cause spreading of embry-
onic cells along the migratory pathway during fetal organogenesis
with potential to induce lesions including both endometriosis and
ovarian neoplasms (Fujii, 1991; Redwine, 1998; Varma et al., 2004;
Batt et al., 2007; Mandai et al., 2009; Signorile et al., 2009). Our
data are in relation with another study that described presence
of endometriotic foci adjacent to the embryonic duct remnants
of coelomic origin involving ovaries and fallopian tubes in three
among 18 adult patients (Mai et al., 1998). Phenotypically, the
epithelial cells of the duct remnants appeared transformed and
showed a diffuse but weak immunoreactivity for estrogen receptor
(Mai et al., 1998). The findings of embryonic ducts spread in broad
ligaments and under the fallopian tube serosa in our series could be
related to studies describing occurrence of endometriomas as well
as neoplasms of a Müllerian origin in these locations (Zacharia
and O’Neill, 2006; Handa et al., 2007; Wei et al., 2011). Finally, the
aberrant and consistent expression of alpha-1-fetoprotein revealed
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in the embryonic ducts in two fetuses is in accordance with other
studies that reported de novo expression of this protein in ovar-
ian malignancy arising from endometriosis (Horiuchi et al., 1998;
Certin et al., 2007; Takahashi et al., 2011).
In conclusion, the presented data support the theory that at
least some subtypes of endometriotic and gynecological neoplastic
lesions may be related to anomalies occurring during the embryo-
genesis. These data stand in relationship with the embryolog-
ical origin of certain pelvic malignancies based on the meta-
plastic potentiality of the secondary Müllerian system. The
observed frequency of displaced embryonic structures, also sug-
gests a complex pathogenetic mechanism in the development of
endometriosis-associated neoplasms including genetic, hormonal,
and/or environmental events. Consequently, further studies of
endometriotic and neoplastic lesions should include novel embry-
onic cellular phenotypic markers, that could provide important
diagnostic and predictive information to guide clinical decision
making.
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